AI assistant
CORCEPT THERAPEUTICS INC — Director's Dealing 2012
Apr 2, 2012
30681_dirs_2012-04-02_787ad4f2-011b-4f83-a993-ae188c843473.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-03-29
Reporting Person: BIRD JEFFREY W (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-29 | Common Stock | X | 12643.0000 | $2.9600 | Acquired | 242210.0000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-29 | Common Stock Warrant | $4.0500 | P | 12643.0000 | Acquired | 2015-03-29 | Common Stock (12643.0000) | Indirect |
| 2012-03-29 | Common Stock Warrant | $2.9600 | X | 12643.0000 | Disposed | 2013-04-21 | Common Stock (12643.0000) | Indirect |
Footnotes
F1: Issuance of common stock upon exercise of warrants in accordance with the Warrant Purchase Agreement dated as of April 21, 2010.
F2: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.
F3: Acquired from the issuer pursuant to a Warrant Purchase Agreement dated March 25, 2012, whereby purchase of the new warrants was conditioned upon the exercise of warrants that had been issued on April 21, 2010 (see also Footnote #1 above).